小鵬汽車-W(09868.HK)與大眾汽車簽訂戰略技術合作聯合開發協議
小鵬汽車-W(09868.HK)公布,與大眾汽車集團簽訂平台與軟件戰略技術合作聯合開發協議,標誌著雙方戰略合作取得里程碑式重大進展。聯合開發協議的簽訂,不僅將加速兩款B級純電動汽車的聯合研發,也為雙方更廣泛、深入的戰略合作,奠定堅實的基礎。
作為聯合開發協議的重要組成部分,小鵬汽車與大眾汽車還就雙方車型及平台的共用零部件,訂立了聯合採購計劃。通過整合雙方規模優勢以及依託大眾汽車世界級的供應鏈能力,聯合採購計劃旨在合力降低平台成本,充分發揮戰略合作的協同效應,提升雙方共同開發的B級純電車型的產品力。
小鵬汽車董事長兼首席執行官何小鵬表示,通過聯合採購計劃,協同效應已經開始兌現,深信雙方的合作夥伴關係蘊藏廣闊前景,雙方將進一步攜手探索。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.